https://scholars.lib.ntu.edu.tw/handle/123456789/631864
標題: | Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial | 作者: | Heo, Jeong JA-DER LIANG Kim, Chang Won Woo, Hyun Young I-LUN SHIH TUNG-HUNG SU ZHONG-ZHE LIN Yoo, So Young Chang, Stanley Urata, Yasuo PEI-JER CHEN |
關鍵字: | OBP-301; advanced hepatocellular carcinoma; clinical and translational; hTERT promoter; oncolytic adenovirus; suratodenoturav; telomerase reverse transcriptase gene; tumor microenvironment | 公開日期: | 14-四月-2023 | 來源出版物: | Molecular therapy : the journal of the American Society of Gene Therapy | 摘要: | OBP-301 is an oncolytic adenovirus modified to replicate within cancer cells and lyse them. This open-label, non-comparative, phase I dose-escalation trial aimed to assess its safety and optimal dosage in 20 patients with advanced hepatocellular carcinoma. Good tolerance was shown with a maximum tolerated dose of 6 × 1012 viral particles. The most common treatment-emergent adverse events were influenza-like illness, pyrexia, fatigue, decreased platelet count, abdominal distension, and anemia. Cohorts 4 and 5 had approximately 50% higher levels of CD8+ T cells in the peripheral blood after injection. The best target response occurred in 14 patients, 4 of whom had progressive disease. Multiple intratumoral injections of OBP-301 were well tolerated in patients with advanced hepatocellular carcinoma. The stable disease rate for the injected tumors was greater than the overall response rate, even with no obvious tumor response. OBP-301 might have a greater impact on local response as histological examination revealed that the presence of OBP-301 was consistent with the necrotic area at the injection site. Increased infiltration of CD8+ T cells and <1% PD-L1 expression were observed in tumors after injection. Improved antitumor efficacy might be achieved in future studies via viral injection with volume adjustment and in combination with other immuno-therapeutics. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/631864 | ISSN: | 15250016 | DOI: | 10.1016/j.ymthe.2023.04.006 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。